David Osband

David Osband's work experience begins with their current role as EVP, Sales and Marketing at Sword Bio, a bioanalytical CRO specializing in developing and validating assays for pharmaceutical projects. David joined Sword Bio in February 2023.

Prior to their current position, David served as President of Nexus Medical Labs from February 2022 to December 2022.

From January 2021 to January 2022, David worked as SVP, Diagnostics at Seaport Diagnostics.

In 2020, David held the role of Director/Head, Diagnostics Business Development at BioAgilytix.

David's earlier experience includes working at Cambridge Biomedical Inc., where they served as Director of Sales from July 2015 to December 2019. David also served as a Board Member from January 2016 to November 2019 and as an Account Executive from June 2009 to July 2015.

Before entering the field of biotechnology and diagnostics, David worked in the real estate finance industry. David held positions such as Director at N2 Realty Capital from December 2008 to April 2009, Vice President at Pinecrest National Funding from August 2007 to September 2008, and Vice President at Madison Realty Capital from September 2006 to August 2007.

David Osband attended Yeshiva University from 2003 to 2006, where they obtained a Bachelor of Science degree in Marketing.